Multiple Sclerosis, Relapsing-Remitting
-
Subject Areas on Research
- 1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS.
- Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.
- Analysis of normal-appearing white matter in multiple sclerosis: comparison of diffusion tensor MR imaging and magnetization transfer imaging.
- Brain metabolite profiles of T1-hypointense lesions in relapsing-remitting multiple sclerosis.
- Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.
- Identifying Patients With Relapsing-Remitting Multiple Sclerosis Using Algorithms Applied to US Integrated Delivery Network Healthcare Data.
- Important sources of variability in clinical studies of neutralizing antibodies against interferon beta.
- Safety and immunologic effects of high- vs low-dose cholecalciferol in multiple sclerosis.
- Serum phosphorylated neurofilament-heavy chain levels in multiple sclerosis patients.
- Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.